Gene Therapy of Human Melanoma. Immunization of Patients with Autologous Tumor Cells Admixed with Allogeneic Melanoma Cells Secreting Interleukin 6 and Soluble Interleukin 6 Receptor. University School of Medical Sciences at GreatPoland Cancer Center, Poznań, Poland
- 1 June 1995
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 6 (6) , 805-811
- https://doi.org/10.1089/hum.1995.6.6-805
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.This publication has 23 references indexed in Scilit:
- Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.Journal of Clinical Investigation, 1994
- Differential shedding of the two subunits of the interleukin‐6 receptorFEBS Letters, 1993
- Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic MelanomaaAnnals of the New York Academy of Sciences, 1993
- IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine KinaseScience, 1993
- Combined therapy with IL‐6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomasInternational Journal of Cancer, 1993
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990
- Antitumor activity of recombinant interleukin 6 in mice.The Journal of Experimental Medicine, 1990
- Soluble cytokine receptors are present in normal human urine.The Journal of Experimental Medicine, 1989
- Melanoma-Specific Cytotoxic T Cells Generated from Peripheral Blood LymphocytesAnnals of Surgery, 1989
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989